These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 16555621)
1. The management of mechanical hearts. Mudge GH Trans Am Clin Climatol Assoc; 2005; 116():283-91; discussion 292. PubMed ID: 16555621 [TBL] [Abstract][Full Text] [Related]
2. The physiologic basis for the management of ventricular assist devices. Mudge GH; Fang JC; Smith C; Couper G Clin Cardiol; 2006 Jul; 29(7):285-9. PubMed ID: 16881535 [TBL] [Abstract][Full Text] [Related]
3. Cardiac extracorporeal life support: state of the art in 2007. Cooper DS; Jacobs JP; Moore L; Stock A; Gaynor JW; Chancy T; Parpard M; Griffin DA; Owens T; Checchia PA; Thiagarajan RR; Spray TL; Ravishankar C Cardiol Young; 2007 Sep; 17 Suppl 2():104-15. PubMed ID: 18039404 [TBL] [Abstract][Full Text] [Related]
4. Improving outcomes with long-term "destination" therapy using left ventricular assist devices. Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385 [TBL] [Abstract][Full Text] [Related]
5. Current status of mechanical circulatory assistance. Stone ME Semin Cardiothorac Vasc Anesth; 2007 Sep; 11(3):185-204. PubMed ID: 17711971 [TBL] [Abstract][Full Text] [Related]
7. Demystifying ventricular assist devices. Litton KA Crit Care Nurs Q; 2011; 34(3):200-7. PubMed ID: 21670618 [TBL] [Abstract][Full Text] [Related]
8. The future is here: ventricular assist devices for the failing heart. Alba AC; Delgado DH Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1067-77. PubMed ID: 19764860 [TBL] [Abstract][Full Text] [Related]
9. Ventricular assist devices the challenges of outpatient management. Wilson SR; Givertz MM; Stewart GC; Mudge GH J Am Coll Cardiol; 2009 Oct; 54(18):1647-59. PubMed ID: 19850205 [TBL] [Abstract][Full Text] [Related]
10. Left ventricular device as destination therapy: are we there yet? Badiwala MV; Rao V Curr Opin Cardiol; 2009 Mar; 24(2):184-9. PubMed ID: 19532106 [TBL] [Abstract][Full Text] [Related]
11. Outpatient use of left ventricular assist devices: nursing, technical, and educational considerations. Moroney DA; Powers K Am J Crit Care; 1997 Sep; 6(5):355-62. PubMed ID: 9283672 [TBL] [Abstract][Full Text] [Related]
12. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices. Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570 [TBL] [Abstract][Full Text] [Related]
14. [End-stage heart failure: role of various circulation assistance techniques]. Leprince P; Pavie A; Léger P; Bonnet N; Bors V; Levasseur JP; Vaissier E; Gandjbakhch I Ann Cardiol Angeiol (Paris); 2000 Feb; 49(1):27-36. PubMed ID: 12555318 [TBL] [Abstract][Full Text] [Related]
15. Perioperative management of ventricular assist devices in children and adolescents. Dickerson HA; Chang AC Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2006; ():128-39. PubMed ID: 16638558 [TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of partial ventricular support in chronic heart failure: results of simulation validated with in vivo data. Morley D; Litwak K; Ferber P; Spence P; Dowling R; Meyns B; Griffith B; Burkhoff D J Thorac Cardiovasc Surg; 2007 Jan; 133(1):21-8. PubMed ID: 17198776 [TBL] [Abstract][Full Text] [Related]
17. Percutaneous left ventricular assist devices for treatment of patients with cardiogenic shock. Windecker S Curr Opin Crit Care; 2007 Oct; 13(5):521-7. PubMed ID: 17762230 [TBL] [Abstract][Full Text] [Related]
18. Destination therapy: does progress depend on left ventricular assist device development? von Bayern MP; Cadeiras M; Deng MC Heart Fail Clin; 2007 Jul; 3(3):349-67. PubMed ID: 17723941 [TBL] [Abstract][Full Text] [Related]
19. Improved durability of the HeartMate XVE left ventricular assist device provides safe mechanical support up to 1 year but is associated with high risk of device failure in the second year. Martin J; Friesewinkel O; Benk C; Sorg S; Schultz S; Beyersdorf F J Heart Lung Transplant; 2006 Apr; 25(4):384-90. PubMed ID: 16563965 [TBL] [Abstract][Full Text] [Related]
20. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]